Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions

Studies describing invasive fungal infections (IFIs) after chimeric antigen receptor-modified T-cell (CAR-T-cell) therapy are limited. Although post-CAR-T-cell IFIs appear to be uncommon, they are associated with significant morbidity and mortality. Specific risk factors for IFIs in CAR-T-cell recip...

Descripción completa

Detalles Bibliográficos
Autores principales: Garner, Will, Samanta, Palash, Haidar, Ghady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927024/
https://www.ncbi.nlm.nih.gov/pubmed/33672208
http://dx.doi.org/10.3390/jof7020156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927024/
https://www.ncbi.nlm.nih.gov/pubmed/33672208
http://dx.doi.org/10.3390/jof7020156

Ejemplares similares